Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.04 - $0.13 $458,398 - $1.49 Million
-11,459,973 Reduced 74.12%
4,001,856 $280,000
Q3 2023

Nov 14, 2023

SELL
$0.12 - $0.5 $21,743 - $90,597
-181,194 Reduced 1.16%
15,461,829 $2.01 Million
Q1 2023

May 15, 2023

SELL
$0.46 - $0.81 $249,768 - $439,809
-542,975 Reduced 3.35%
15,643,023 $9.86 Million
Q4 2022

Feb 14, 2023

BUY
$0.5 - $261.0 $771,519 - $403 Million
1,543,039 Added 10.54%
16,185,998 $10.5 Million
Q3 2022

Nov 14, 2022

BUY
$1.04 - $322.5 $538,595 - $167 Million
517,880 Added 3.67%
14,642,959 $25.2 Million
Q2 2022

Aug 15, 2022

BUY
$0.41 - $1.24 $45,914 - $138,862
111,986 Added 0.8%
14,125,079 $17.5 Million
Q1 2022

May 16, 2022

BUY
$0.62 - $1.17 $413,292 - $779,922
666,600 Added 4.99%
14,013,093 $9.14 Million
Q4 2021

Feb 14, 2022

BUY
$1.09 - $1.89 $872,000 - $1.51 Million
800,000 Added 6.38%
13,346,493 $14.5 Million
Q3 2021

Nov 15, 2021

BUY
$1.44 - $2.73 $85,343 - $161,796
59,266 Added 0.47%
12,546,493 $22.8 Million
Q2 2021

Aug 16, 2021

BUY
$2.63 - $3.67 $1.15 Million - $1.6 Million
437,220 Added 3.63%
12,487,227 $33 Million
Q1 2021

May 17, 2021

BUY
$2.82 - $5.6 $163,514 - $324,710
57,984 Added 0.48%
12,050,007 $43.4 Million
Q4 2020

Feb 16, 2021

BUY
$2.09 - $3.09 $3.31 Million - $4.9 Million
1,585,173 Added 15.23%
11,992,023 $30.2 Million
Q3 2020

Nov 16, 2020

BUY
$2.39 - $3.43 $1.83 Million - $2.62 Million
764,090 Added 7.92%
10,406,850 $26.2 Million
Q2 2020

Aug 14, 2020

BUY
$2.2 - $3.71 $220,000 - $371,000
100,000 Added 1.05%
9,642,760 $31.6 Million
Q1 2020

May 15, 2020

BUY
$1.9 - $4.98 $9.21 Million - $24.1 Million
4,846,014 Added 103.18%
9,542,760 $23.4 Million
Q4 2019

Feb 14, 2020

BUY
$3.95 - $5.35 $2 Million - $2.71 Million
505,619 Added 12.06%
4,696,746 $22.2 Million
Q3 2019

Nov 14, 2019

BUY
$4.13 - $6.94 $5.95 Million - $9.99 Million
1,439,739 Added 52.33%
4,191,127 $17.9 Million
Q2 2019

Aug 14, 2019

BUY
$3.98 - $6.2 $3.96 Million - $6.17 Million
994,575 Added 56.61%
2,751,388 $16 Million
Q1 2019

May 15, 2019

BUY
$2.0 - $4.4 $3.51 Million - $7.73 Million
1,756,813 New
1,756,813 $6.76 Million

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $458M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Discovery Capital Management, LLC Portfolio

Follow Discovery Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Discovery Capital Management, LLC , based on Form 13F filings with the SEC.

News

Stay updated on Discovery Capital Management, LLC with notifications on news.